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ABSTRACT OF THESIS

ETHANOL SUSTAINS PHOSPHORYLATED TAU PROTEIN
IMMUNOFLUORESCENCE IN THE CULTURED NEONATAL RAT
HIPPOCAMPUS: IMPLICATIONS FOR FETAL ALCOHOL SPECTRUM
DISORDERS
Fetal Alcohol Spectrum Disorders (FASDs) are comprised of developmental,
behavioral, and cognitive abnormalities caused by prenatal alcohol exposure, affecting an
estimated 2%-5% of children and costing up to $4 billion annually in the United States
alone. Although some behavioral therapies can help, the biochemical mechanisms that
underpin FASDs need further elucidation for development of more efficacious
therapeutics. The tau protein modulates cytoskeletal structure in neurons, and thereby plays
an integral role in proper development and function of the central nervous system, but its
function is altered by its phosphorylation state, such that increased phosphorylation reduces
tau protein function. The tau protein is highly phosphorylated at birth but becomes
dephosphorylated during structural maturation. Aberrant tau hyperphosphorylation is
cardinal of neurodegenerative diseases, but less is known about its role in
neurodevelopmental disorders, like FASD. In the neonatal rat model of organotypic
hippocampal slice culture, tau phosphorylation decremented in all measured regions of the
control hippocampus across 24 days in vitro, but tau hyperphosphorylation was sustained
in all regions except the CA3 in hippocampal slices that were exposed to alcohol. Future
research should investigate the functional, behavioral, and cognitive relevance of
hyperphosphorylated tau protein with regard to FASDs to identify potential therapeutics.
KEYWORDS: Tauopathy, Fetal Alcohol Spectrum Disorders, Organotypic Hippocampal
Slice Culture
Caleb Seth Bailey
(Name of Student)
10/28/2020
Date

ETHANOL SUSTAINS PHOSPHORYLATED TAU PROTEIN
IMMUNOFLUORESCENCE IN THE CULTURED NEONATAL RAT
HIPPOCAMPUS: IMPLICATIONS FOR FETAL ALOCHOL SPECTRUM
DISORDERS

By
Caleb Seth Bailey

Dr. Mark A. Prendergast
Director of Thesis
Dr. Mark Fillmore
Director of Graduate Studies
10/28/2020
Date

DEDICATION
Joy Briggs, Daisy, and John Prine

ACKNOWLEDGMENTS
I would like to extend thanks to my advisor, Dr. Mark Prendergast, and my
committee members, Drs. Josh Beckmann and Mike Bardo, for their advice, guidance,
and support to conduct these experiments.
These experiments could not have been accomplished without the assistance of
my senior lab mate, Julia Jagielo-Miller. Her constructive insight, willingness to help,
and graduate mentorship are invaluable assets which are simply manifestations of her
selfless personality.
A special gratitude is owed to Dr. Peggy Keller for her expertise in data analysis
and willingness to put in hours at a time to help me understand multilevel modeling.
Certainly, this work could not have been accomplished without the hands of our
undergraduate research assistants, Abigail Wilcox and Caroline Heltsley; data collection
would not have been possible without your help.
Lastly, I am thankful for the remote support offered by my family and friends in
Tennessee – the list of whom would be longer than this document.

iii

TABLE OF CONTENTS

ACKNOWLEDGMENTS ................................................................................................. iii
LIST OF TABLES ............................................................................................................. vi
LIST OF FIGURES .......................................................................................................... vii
CHAPTER 1. INTRODUCTION ....................................................................................... 1
1.1 Fetal Alcohol Spectrum Disorders.......................................................................... 1
1.1.1 Intelligence...................................................................................................... 2
1.1.2 Attention ......................................................................................................... 3
1.1.3 Executive Functioning .................................................................................... 4
1.1.4 Adaptive Functioning...................................................................................... 4
1.1.5 Learning and Memory..................................................................................... 5
1.2 Convergent Mechanisms of Pathology in the Hippocampus .................................. 6
1.2.1 Neural Cytography .......................................................................................... 7
1.2.2 Amino Acid Neurotransmission ..................................................................... 7
1.2.3 Hippocampal Pathology .................................................................................. 8
1.2.4 Convergent Mechanisms................................................................................. 9
1.2.5 Alcohol Action ................................................................................................ 9
1.2.6 Microtubule Involvement.............................................................................. 10
1.3 Tau Protein Function: Modifications and Pathologies ........................................ 11
1.3.1 Ubiquitination ............................................................................................... 12
1.3.2 Glycosylation ................................................................................................ 13
1.3.3 Hyperphosphorylation................................................................................... 14
1.4 Purpose ................................................................................................................. 15
CHAPTER 2. METHODS ................................................................................................ 16
2.1 Organotypic Hippocampal Slice Culture.............................................................. 16
2.2 Experiment 1: Temporal Assessment of Tau Protein Phosphorylation in the
Hippocampus ................................................................................................................ 17
2.3 Experiment 2 Effect of Initial Alcohol Exposure on Temporal Decrement of Tau
Protein Phosphorylation in the Hippocampus .............................................................. 18
2.4 Immunohistochemistry Procedure ........................................................................ 19
2.5 Statistical Analysis ................................................................................................ 20
CHAPTER 3. RESULTS .................................................................................................. 21
3.1 Experiment 1. ........................................................................................................ 21
iv

3.2 Experiment 2 ......................................................................................................... 24
3.2.1 Differences in intensity across age groups based on region and EtOH
exposure .................................................................................................................... 27
CHAPTER 4. DISCUSSION ............................................................................................ 32
4.1 Implications........................................................................................................... 32
4.1.1 Experiment 1 ................................................................................................. 32
4.1.2 Experiment 2 ................................................................................................. 33
4.2 Limitations ............................................................................................................ 35
REFERENCES ................................................................................................................. 37
VITA ................................................................................................................................ 50

v

LIST OF TABLES
Table 3.1.1 Results from the multilevel model analysis for Experiment 1……................ 22
Table 3.2.1 Results from the multilevel model analysis for Experiment 2……………... 26

vi

LIST OF FIGURES
Figure 2.2.1 Experimental Timeline…………………………………………………….. 17
Figure 2.2.2 Regions of Interest for Experiment 1………………………………………. 17
Figure 2.3.1 Regions of Interest for Experiment 2………………………………………. 18
Figure 3.1.1 Average effect of days in vitro on p-Tau Thr231 immunofluorescence across
6, 12, 18, and 24DIV……………………………………………………………………. 23
Figure 3.2.1.1 Effect of alcohol and days in vitro on p-Tau Thr231 immunofluorescence
across 12, 18, and 24DIV in the dentate gyrus………………......................................... 28
Figure 3.2.1.2 Effect of alcohol and days in vitro on p-Tau Thr231 immunofluorescence
across 12, 18, and 24DIV in the CA3…………………………………………………... 29
Figure 3.2.1.3 Effect of alcohol and days in vitro on p-Tau Thr231 immunofluorescence
across 12, 18, and 24DIV in the CA1………………………..…………………………. 30
Figure 3.2.1.4 Effect of alcohol and days in vitro on p-Tau Thr231 immunofluorescence
across 12, 18, and 24DIV in the hippocampal genu………………………..…………... 31

vii

CHAPTER 1. INTRODUCTION
1.1

Fetal Alcohol Spectrum Disorders
Fetal Alcohol Spectrum Disorders (FASD) is a non-diagnostic umbrella term

which includes patients who are diagnosed with partial or full Fetal Alcohol Syndrome
(pFAS; FAS), alcohol-related neurodevelopmental disorder (ARND), alcohol-related
birth defects (ARBD), and neurobehavioral disorder associated with prenatal alcohol
exposure (ND-PAE). These conditions are diagnostically spectral, with FAS patients
presenting a greater magnitude of physical (lower birth weight, thin vermilion, smooth
philtrum, flat midface, shortened palpebral fissure) and neurodevelopmental
(microcephaly, cerebellar hypoplasia) abnormalities compared to other FASDs (Bertrand
et al., 2004; Ferreira & Cruz, 2017; Jones & Smith, 1973; Kully-Martens, Denys, Treit,
Tamana, & Rasmussen, 2019). Though FASDs are the most preventable causes of mental
retardation, an estimated 2-5% of children are affected by FASDs and disburse up to $4
billion in annual costs in the United States alone (Lupton, Burd, & Harwood, 2004; May
et al., 2009). Recently, up to 11.5% of women reported drinking during the time of
pregnancy, and 3.9% reported binge drinking within the last 30 days of the pregnancy
(Denny, Acero, Naimi, & Kim, 2019). In some domains, binge alcohol consumption
during pregnancy induces more severe deficits compared to moderate, chronic alcohol
consumption (Bonthius, Goodlett, & West, 1988; Sood et al., 2001) though no amount of
alcohol consumption is safe at any stage of pregnancy (Williams & Smith, 2015).
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Alcohol exposure at different fetal stages has varying effects on the developing
central nervous system (CNS); earlier fetal alcohol exposure during the embryonic periods
results in the cardinal craniofacial abnormalities in the human along with forebrain and
brain stem developmental perturbations in macaques and Sprague-Dawley rats,
respectively (Ernhart et al., 1987; Miller, 2007; Mooney & Miller, 2007; Sulik, 2005). Data
from both rodent and human studies show that alcohol exposure prior to and briefly after
birth has a greater magnitude of influence on neural and glial migration and viability,
resulting in hippocampal, cortical, and corpus colossal defects leading to diminished
overall brain volume and white matter insulation compared to unexposed groups (Gressens,
Lammens, Picard, & Evrard, 1992; Miller, 1995; Riley et al., 2005; Rubert, Miñana,
Pascual, & Guerri, 2006; Sowell et al., 2001). These deficits result in several behavioral
and cognitive abnormalities in humans which practitioners primarily rely on for diagnosis
(Mattson, Crocker, & Nguyen, 2011). Notable deficits observed in FASDs include, but are
not limited to, diminished intellectual capacity, attention, executive and adaptive
functioning, and learning and memory.
1.1.1

Intelligence
In general, individuals with FASDs have a restricted intellectual capacity with a

broad IQ range between 20-120 (Mattson & Riley 1998; Streissguth, Barr, Kogan, &
Bookstein, 1996); however, even those most severely affected by FASDs usually have
IQs greater than 70 (i.e. do not meet criteria for intellectual disability; Mattson et al.,
2011). Chasnoff et al. (2010) showed that there are some intellectual distinctions between
FAS, pFAS, and ARND with regard to IQ and language-based memory where,
predictably, individuals with FAS scored significantly worse than those with pFAS and
2

ARND; notably, there were no significant differences in any neurocognitive assessment
between individuals with pFAS and ARND. Intelligence research on individuals with
lower exposure to prenatal alcohol (pFAS and ARND) is lacking and many outcomes are
inconclusive in part due to poor reporting of the timing and amount of alcohol exposure
(Henderson, Gray, & Brocklehurst, 2007). Importantly, children with FASDs consistently
perform worse in academic domains compared to non-FASDs children even after
controlling for IQ, suggesting that general intelligence may only be one component of a
milieu of neurocognitive factors that predict suboptimal academic performance (Glass et
al., 2017; Goldschmidt et al., 1996).
1.1.2

Attention
Individuals with FASDs also show attention deficits and hyperactivity (Lee,

Mattson, & Riley, 2007). Some of the most common attentional deficits seen in FASDs
include efficiency of information processing, working memory, impulsivity, and reaction
time – symptoms which overlap with attention deficit hyperactive disorder (ADHD;
Jacobson, Jacobson, & Sokol, 1994; Kodituwakku, 2009; Rasmussen, 2005; Streissguth,
2007). In fact, the cognitive and behavioral abnormalities between FASDs and ADHD
are strikingly similar, though individuals with FASDs generally have lower IQs
compared to individuals with ADHD (Bhatara, Loudenberg, & Ellis, 2006; Vaurio, Riley,
Mattson, 2008; for a review, see Mattson, Bernes, & Doyle, 2019). FASDs remain the
highest risk factor for developing ADHD in children, with prevalence of ADHD in
individuals with FASDs reaching up to 94% (Bhatara et al., 2006; Fryer, McGee, Matt,
Riley, & Mattson, 2007). This prevalence reflects the similar behavioral and cognitive
presentations between FASDs and ADHD, but it should be noted that the diagnostic
3

distinctions may be muddied. An estimated >90% cases of FASDs are mis- or
undiagnosed (Chasnoff, Wells, & King, 2015), which is likely due to the stigmatization
and underreporting of maternal alcohol use (Corrigan et al., 2017; Morleo, 2011).
1.1.3

Executive Functioning
Children with FASDs present with poor executive functioning. Executive

functioning encompasses some components of attention and appropriate physical activity
levels, but additionally incorporates competency in problem solving, concept formation,
set-shifting, and planning to achieve goal-directed behaviors (Anderson, 2002; Welsh &
Pennington, 1988). Children with FASDs show significant deficits in the ability to
generate and appropriately categorize abstract ideas when prompted; additionally, it has
been shown that executive functioning may be impaired in individuals with FASDs due
to the compounding difficulties with working memory and selective attention (Aragón,
2008; McGee, Schonfeld, Roebuck-Spencer, Riley, & Mattson, 2008; Rasmussen, 2005).
Subsequently, these executive functioning deficits impede on or entirely disrupt
conceptualization, reasoning, and planning skills (Kodituwakku, Handmaker, Cutler,
Weathersby, & Handmaker, 1995; McGee et al., 2008), which ultimately influence daily
life and impair adaptive functioning. Taken together, this creates a familial, economic,
and societal burden for those affected by FASDs (Greenmyer, Klug, Kambeitz, Popova,
& Burd, 2018).
1.1.4

Adaptive Functioning
Diagnostic features of adaptive functioning operate within the three realms of

communication, socialization, and daily living skills and are commonly evaluated using
4

the Vineland-3 assessment for individuals with intellectual disabilities (Sparrow,
Cicchetti, & Saulnier, 2016). Cumulatively, these components promote personal and
social independence – traits which are substandard in adult individuals with FASDs;
these deficits are particularly exacerbated in conjunction with sensory processing deficits
which is a common feature in those with FASDs (Åse et al., 2012; Jirikowic, Olson, &
Kartin, 2008; Carr, Agnihotri, & Keightley, 2010). The affective impact of poor adaptive
functioning in social outcomes in the FASDs population poses a significant risk of
developing psychological disorders (Famy, Streissguth, & Unis, 1998; Fryer et al., 2007;
O'Connor & Paley, 2009; for a review, see Weyrauch, Schwartz, Hart, Klug, & Burd,
2017). Further, individuals prenatally exposed to alcohol are more likely to present with
conduct disorders, substance use disorders, and legal trouble (Alati et al., 2008; Larkby,
Goldschmidt, Hanusa, & Day, 2011; Streissguth et al., 2004).
1.1.5

Learning and Memory
Children with FASDs have impaired learning and memory skills regardless of IQ

(Lewis et al., 2015; Mattson et al., 2011). Several of the deficits mentioned herein
contribute to poor learning and memory outcomes in humans with FASDs, including
attention, information processing, cognitive set shifting, working memory, and executive
functioning (Aragón, 2008; Lee et al., 2007; Rasmussen, 2005). Poor memory
consolidation, slower information processing and inefficient working memory are likely
manifestations of the deleterious effects of alcohol on the developing hippocampus; in
fact, magnetic resonance imaging (MRI) has revealed that truncated hippocampal
development in FASDs is associated with impaired recall as evidenced by reduced
hippocampal volume compared to age-matched controls (Willoughby, Sheard, Nash, &
5

Rovet, 2008). In pre- and neonatal alcohol-exposure rodent models of FASDs, alcohol
exposure induces visuospatial learning and recall deficits, which is shown by a marked
impairment to reach the escape platform in the Morris Water Maze Task compared to
rodents who were not exposed to alcohol (Berman & Hannigan, 2000; Goodlett &
Johnson, 1997; Johnson & Goodlett, 2002). Wagner, Zhou, and Goodlett (2014) showed
that learning deficits resulting from rodent neonatal binge alcohol exposure (human 3rd
trimester equivalent) can persist into adolescence and adulthood. Due to its plastic role in
learning and memory and susceptibility to alcohol insult, the hippocampus is an attractive
candidate for investigation and potential mitigation of the developmental deficits
observed in FASDs.

1.2

Convergent Mechanisms of Pathology in the Hippocampus
The functional role of the hippocampus is primarily involved in the synthesis and

retrieval of episodic and contextual memories (Moscovitch, Nadel, Winocur, Gilboa, &
Rosenbaum, 2005). Although the role of the hippocampus in long-term memory retrieval
is debated, there is evidence to suggest that the hippocampus is necessary for long-term
contextual and autobiographical retrieval in rodents and humans, respectively (Rekkas &
Constable, 2005; Steinvorth, Levine, & Corkin, 2005; Sutherland, O'Brien, & Lehmann,
2008). The synthesis of new memories is perhaps the most important role of the
hippocampus and is certainly the most debilitating deficit in diseased and damaged states
of the hippocampus. Memory-related pathologies such as age-related dementia and
Alzheimer’s Disease (AD) target the hippocampus and the entorhinal cortex, though there
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are distinct pathologies for each with respect to subregional hippocampal damage within
the perforant pathway (Small, Schobel, Buxton, Witter, & Barnes, 2011).
1.2.1

Neural Cytography
The trisynaptic perforant pathway is comprised of the entorhinal cortex, dentate

gyrus (DG), Cornu Ammonis 3 (CA3) subregion, Cornu Ammonis 2 (CA2) subregion,
Cornu Ammonis (CA1) subregion, and the subiculum (Cembrowski & Spruston, 2019).
The most explored regions of the hippocampus are the DG, CA3, and CA1 while greater
contention exists over and less is known about the CA2 subregion (Small et al., 2011).
Cell types that pervade the trisynaptic perforant pathway include granule cell layers of
the DG which project mossy fiber axons toward interneurons and pyramidal neurons in
the CA3; pyramidal neurons project Shaffer collateral axons throughout the pyramidal
neurons of the CA3 and CA2 toward pyramidal neurons in the CA1 (Andersen, Bliss, &
Skrede, 1971; Small et al., 2011). The heterogeneity of the pyramidal neurons in the
Cornu Ammonis (CA) regions remains under investigation, but current research suggests
that their functional differences may rely on the length of their distal dendrites which
would modify propensities to fire signals (Cembrowski & Spruston, 2019; Ding et al.,
2020).
1.2.2

Amino Acid Neurotransmission
The trisynaptic perforant pathway implements GABAergic neurotransmission via

laced interneurons and primarily glutamatergic neurotransmission in the granule and
pyramidal cells, though it has been reported that there is a GABA presence in the granule
cells and mossy fiber axons (Acsády, Kamondi, Sík, Freund, & Buzsáki, 1998; Münster7

Wandowski, Gómez-Lira, & Gutiérrez, 2013; Sloviter, 2003). Constitutive activity in the
trisynaptic pathway involves excitatory input from the entorhinal cortex into the granule
cells of the DG which release glutamate onto pyramidal cells and interneurons within the
CA3 and CA2 regions; this results in at least two cellular responses: 1) pyramidal
neurons in these regions propagate excitatory information into subiculum pyramidal cells
along the Shaffer collaterals through the pyramidal cells of the CA1; 2) interneurons in
the CA3, CA2 and CA1 regions regulate and tune pyramidal neuron activity by lateral
inhibition (Banke & McBain, 2006; O’Mara, 2005; Sloviter, 2003). It is through this
glutamatergic N-methyl-D-aspartate (NMDA) mechanism that neural plasticity and longterm potentiation occur in the hippocampus (Collingridge, Kehl, & McLennan, 1983;
Rebola, Lujan, Cunha, & Mulle, 2008). The interaction of this amino acid
neurotransmission is fragile and can contribute to mental illness.
1.2.3

Hippocampal Pathology
In certain pathogenic states, amino acid neurotransmission is dysregulated.

Namely, individuals suffering from AD and epilepsy experience heightened hippocampal
glutamate activity (Barker & White, 2015; Wang & Reddy, 2017), and individuals with
Schizophrenia have a reduced number of hippocampal GABAergic interneurons resulting
in unregulated excitation (Konradi et al., 2011). Unbridled glutamate activity can induce
calcium-mediated mitochondrial dysfunction and excitotoxic neuronal death (Ankarcrona
et al., 1995; Berliocchi, Bano, & Nicotera, 2005). In addition, one hallmark of excessive
glutamate activity in the hippocampus is the presence of collateral axonal sprouting and
reorganization of axons in hyperexcitable pyramidal neurons which is closely associated
with the effects of temporal lobe epilepsy following a sustained seizure (Sutula, Cascino,
8

Cavazos, Parada, & Ramirez, 1989). The clinical overlap between alcohol-related
pathologies and epileptic instances should be noted: the prevalence of epilepsy and
reported history of seizures reaches up to 18%-21% in the FASDs population, which is a
higher prevalence compared to the general population (Bell et al., 2010; Nicita et al.,
2014). This suggests that there may be a common mechanism of hippocampal
modification between alcohol-exposure and development of epileptic profiles.
1.2.4

Convergent Mechanisms
Rodent research on temporal lobe epilepsy may provide an important link

between glutamate activity, hippocampal axonal reorganization, and subsequent cognitive
deficits with relationship to prenatal alcohol exposure. One of the most common
outcomes for successful induction of temporal lobe epilepsy in rodent models is
hyperexcitability of glutamatergic neurons in the hippocampus such that firing threshold
is lower and more sensitive to glutamate (Blümcke et al., 2000; Fritsch, Stott, Joelle
Donofrio, & Rogawski, 2010). This glutamate-driven hippocampal hyperexcitability can
induce neuronal cell death and axonal reorganization, an effect which is replicated by
alcohol exposure and subsequent withdrawal (Ankarcrona et al., 1995; Lindsley, 2006;
Sutula et al., 1989; Whittington, Lambert, & Little, 1995). In fact, upon withdrawal from
heavy, chronic alcohol exposure, both humans and rodents routinely present with seizures
that are perpetuated by robust, imbalanced glutamate activity (Rogawski, 2005).
1.2.5

Alcohol Action
Upon initial exposure, alcohol induces an inhibitory effect on cells by GABA

agonism and glutamatergic antagonism; however, upon withdrawal, alcohol induces a
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compensatory glutamatergic action, surmounting the inhibitory effects of GABA
(Whittington et al., 1995). Importantly, the effects of maternal drinking patterns of
exposure and withdrawal are recapitulated in the developing CNS of the fetus (Thomas &
Riley, 1998). The differential effects of initial alcohol exposure and subsequent
withdrawal on axonal and microtubule organization in the developing rodent brain
remains under investigation. It has been shown that initial alcohol exposure suppresses
axonal growth and guidance cues, but subsequently exaggerates aberrant axonal
sprouting and reorganization in the hippocampus that lasts into adulthood; the nature of
this response may depend on the alcohol dose and the period of CNS development in
which the alcohol exposure occurs (Hodges & Black, 1981; Lindsley, Kerlin, & Rising,
2003; Sakata-Haga et al., 2003). The hippocampal region most susceptible to alcoholinduced microtubule disorganization appears to be the in axonal bend of the intersection
between the CA3 and CA1; this region is imperative for evolution and maintenance of
associative memory and may be linked to cognitive deficits seen in rodent models of
FASDs (Gruart, Muñoz, & Delgado-García, 2006; Sakata-Haga et al., 2003).
1.2.6

Microtubule Involvement
One culprit that may be involved in the poor developmental outcomes associated

with alcohol-induced axonal disorganization could be the regulating effects of
microtubule-associated proteins (MAPs) which are sensitive to alcohol exposure and
have implications in diseased states (Ahluwalia, Ahmad, Adeyiga, Wesley, & Rajguru,
2000; Evrard et al., 2006; Smith, Butler, & Prendergast, 2013). The sprouting of
immature axons incorporates MAPs that directly aid in axonal structural support and
indirectly assist neural migration; one structural protein that is sensitive to alcohol and
10

necessary for appropriate maturation and maintenance of axonal structural support is the
tau protein (Gendron, McCartney, Causevic, Ko, & Yen, 2008). Though the tau protein
is generally investigated with relationship to neurodegenerative diseases such as AD,
Parkinson’s, and dementia, its role in the structural support and susceptibility to alcoholmodulation in the developing nervous system must be considered as a potential element
in the neurodevelopmental profile of FASDs.

1.3

Tau Protein Function: Modifications and Pathologies
Tau proteins are highly involved in the structural integrity of axonal processes in

the central nervous system; the role of tau is integral in several necessary cellular
activities including tubulin polymerization, synaptogenesis, neural migration, axonal
transport, and sustained support of cytoskeletal function (Cleveland, Hwo, & Kirschner,
1977; Dayanandan et al., 1999; Mandelkow, Stamer, Vogel, Thies, & Mandelkow, 2003;
Wang & Liu, 2008). The regulation and function of the tau protein is dynamic and can be
altered at the level of genetic expression, alternative splicing, and posttranslational
modifications in response to cellular insult.
The tau protein is encoded on human chromosome 17q21 and produces six
different isoforms from 16 different exons (Neve, Harris, Kosik, Kurnit, & Donlon,
1986). Tau is in the family of microtubule associated proteins (MAPs) responsible for
tubulin assembly and structural support in mature cells. Alterations to the tau gene
differentially result in diminished tau activity, including poor microtubule binding, an
effect which can result in neurodevelopmental delay and/or degeneration (Bunker,
Kamath, Wilson, Jordan, & Feinstein, 2006; Hong et al., 1998; Shaw-Smith et al., 2006).
11

While not all alterations to the tau gene are associated with any specific pathology, the
alternative splicing of tau exon 10 produces isoforms that include either 3 (3R) or 4 (4R)
microtubule-binding site repeats with functional and pathogenic impacts (Panda, Samuel,
Massie, Feinstein, & Wilson, 2003). Functionally, 4R tau isoforms have triple
microtubule binding capacity than do 3R tau isoforms (D'Souza & Schellenberg, 2005).
In the non-pathogenic human adult brain, the ratio of 3R to 4R tau isoforms is 1:1 and
alterations to this ratio are observed in neurodegenerative diseases such as Parkinson’s
and Down’s syndrome (Heutink, 2000; Yoshida, 2006). Importantly, fetal tau isoforms in
both rodents and humans express only 3 microtubule binding repeats suggesting a
temporal regulation of tau function (Bunker, Wilson, Jordan, & Feinstein, 2004). There is
evidence that tau expression and function is genetically regulated, but posttranslational
modifications substantially interfere with constitutive tau activity and can promote
pathogenic susceptibility. The tau protein is posttranslationally modified primarily by
ubiquitination, glycosylation, and phosphorylation.
1.3.1

Ubiquitination
Ubiquitination of the tau protein results in proteolytic degradation and clearance

of the protein. Ubiquitination is site specific on the tau protein with functionally distinct
proteolytic activity; in the pathogenic state, tau proteins are ubiquitinated by at least three
linkages: Lysine 6, Lysine 11, and Lysine 48 (Wang & Liu, 2008). These linkages have
different outcomes for the tau proteins wherein Lysine 48 is necessary for proteolytic
recruitment, but Lysine 6 appears to be protective against proteasome recruitment (Cripps
et al., 2006). Importantly, ubiquitination is critical for degradation of misfolded proteins
that aggregate and jeopardize cell viability if left unmodified. For instance, proteolytic
12

stress triggers heat shock protein-70 (Hsp70) which interacts with C-terminus of Hsc70interacting protein (CHIP) ubiquitin ligase, or collectively the E3 ligase; this interaction
is effective for clearance of misfolded tau proteins seen in tauopathic brains (Connell et
al., 2001). Moreover, the Hsp70-CHIP interaction is being considered as a diagnostic and
therapeutic tool for tauopathies because of its elevated activity in tauopathies such as AD
(Kumar, Jha, Jha, Ramani, & Ambasta, 2015). In fact, Hsp70-CHIP activity appears to
coincide with hyperphosphorylation of the tau protein, a cardinal correlate of tauopathies
(Shimura, Schwartz, Gygi, & Kosik, 2004).
1.3.2

Glycosylation
Glycosylation is a modification involving the attachment of a carbohydrate group

to an amine side chain (N-linked) or a hydroxyl group (O-linked) of a protein which
alters its structure and function. Glycosylation and deglycosylation are site-specific on
the tau protein and have functional differences dependent on glycosylation site (Gong,
Liu, Grundke-Iqbal, & Iqbal, 2005). Specifically, O-linked monosaccharide β-Nacetylglucosamine glycosylation, or O-GlcNAcylation, occurs when the monosaccharide
molecule is attached to the hydroxyl group of the serine or threonine residues of the tau
protein. This glycosylation can result in subsequent downstream tau phosphorylation that
may induce aberrant tau protein aggregation and/or neuronal membrane permeability,
subcellular hallmarks of neurodegenerative diseases such as dementia and AD (Arnold et
al., 1996; Lui et al., 2002; Takahashi et al., 1999; Torres & Hart, 1984; Wang, GrundkeIqbal, & Iqbal, 1996; Yuzwa & Vocadlo, 2014). Thus, glycosylation may be involved in
the initiation and maintenance of the cytosolic and structural abnormalities resulting from
tau hyperphosphorylation.
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1.3.3

Hyperphosphorylation
Hyperphosphorylation is the result of overactive kinase activity wherein

phosphate molecules are attached at various residue sites of proteins which can impede
on protein function. Hyperphosphorylation of the tau protein is one hallmark of
neurodegenerative pathologies, though the phosphorylation state of the tau protein is
regulated throughout CNS development in a non-pathogenetic manner (Iqbal, Liu, Gong,
& Grundke-Iqbal, 2010). The most clinically investigated tauopathy is AD, which
involves hippocampal and entorhinal cortical white-matter degeneration, unregulated tau
phosphorylation, development of amyloid-β plaques, and neuronal death, all of which
contribute to progressive loss of memory and cognitive function (for a review, see Orr,
Sullivan, & Frost, 2017). The mechanisms of phosphorylation rely on kinase activity at
one or several phosphorylation sites on the protein structure. For example, glycogen
synthase kinase-3β (GSK-3β) phosphorylation of the tau protein upstream from
(Threonine 231) or directly on the microtubule-binding domain (Serine 262) disrupts the
optimal binding capacity and structural function of the tau protein in diseased states
(Gong et al., 2005). Tau interacts with several kinases, but GSK-3β is an attractive
candidate due to its developmental regulation and sensitivity to alcohol.
GSK-3β activity is implicated in the developing fetus where its role is dynamic
and highly involved in the regulation of cellular glucose metabolism and subsequent
neuronal maturation (Jope & Johnson, 2004). As a kinase, GSK-3β is a protein structure
with its own amino acid residues that can be ubiquitinated, glycosylated, and
phosphorylated which dictate its activity. When GSK-3β is dephosphorylated at its
Serine 9 site, it becomes active and such action is elevated following alcohol exposure
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(Chen et al., 2009). It has been reported that unregulated activity of GSK-3β may be
related to alcohol-driven compensatory Ca2+ activity (Hartigan & Johnson, 1999). GSK3β overactivity can result in deleterious fetal effects regarding neurite outgrowth, axon
extension, and microtubule function in the developing CNS which are directly related to
the phosphorylation state of the tau protein; GSK-3β overactivity increases tau
phosphorylation at several amino acid residues and impairs the protein function (Dill,
Wang, Zhou, & Li, 2008; Xu et al., 2004).

1.4

Purpose
Taken together, the observations outlined in the sections above would suggest: (1)

fetal alcohol exposure aberrantly affects microtubule organization in the hippocampus;
(2) this effect is likely modified by alcohol-induced Ca2+ activity which affects fetal
axonal arrangement and increases GSK-3β activity; (3) resulting in sustained tau
phosphorylation within fetal hippocampal axons. We hypothesize that phosphorylated tau
protein immunofluorescence will decrement in control slices; however, we predict that
this immunofluorescence will not decrement in slices that are exposed to alcohol. The
role of alcohol exposure on tau protein phosphorylation in the developing hippocampus is
explored below.
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CHAPTER 2. METHODS
2.1

Organotypic Hippocampal Slice Culture
Ten-day-old male and female Sprague Dawley pups (Harlan Laboratories;

Indianapolis, IN) were humanely euthanized and full brains were aseptically removed and
placed into chilled dissecting media solution containing: Minimum Essential Media
(MEM; Invitrogen, Carlsbad, CA), 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES; Sigma, St. Louis, MO), streptomycin/penicillin (Invitrogen), and Amphotericin
B solution (Sigma). Brains were then midsagittally transected, and hippocampi were
removed. Any excess tissue that was attached to the hippocampi following harvest was
removed using a No. 15 scalpel. These hippocampi were then flatly positioned upon a
plastic platform and sectioned into 200µm slices using the McIllwain Tissue Chopper
(Mickle Laboratory Engineering Co. Ltd., Gomshall, UK). Slices which retained the
CA1, CA3, Genu, and Dentate Gyrus (DG) were then selected to be plated upon Millicell
biopore membranes (0.4μm, 30mm diameter; MilliporeSigma, Burlington,
Massachusetts); each membrane supported 3 to 4 hippocampal slices to prevent tissue
overlap. Membranes were then inserted into 6-well plates (5mL, 9.5cm2 area; VWR,
Radnor, PA) containing approximately 1.5mL of culturing media for humidity-controlled
incubation at 37 °C, 5% CO2, and 95% air. Any excess culturing media that pooled atop
the membrane or around any of the hippocampal slices was removed using a micropipette
to improve slice adherence and ensure oxygen exposure. Slices were permitted 6 days of
uninterrupted incubation to heal from removal and securely anchor into the membrane
prior to any manipulations.
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2.2

Experiment 1: Temporal Assessment of Tau Protein Phosphorylation in the
Hippocampus

At 6 days in vitro (DIV), slices were either transferred into fresh culture media for
later assessment or underwent the IHC procedure for assessment of tau phosphorylation
at 6DIV. The IHC procedure recurred incrementally at 12DIV, 18DIV, and 24DIV to
track the trajectory of tau phosphorylation states across the experimental timeline (Figure
2.2.1). Regions of interest in Experiment 1 included the CA1, CA3, and DG of the
hippocampus (Figure 2.2.2).

Figure 2.2.1 Experimental Timeline. Schematic of timepoints measuring tau phosphorylation
across 6DIV, 12DIV, 18DIV, and 24DIV.

Figure 2.2.2 Regions of Interest for Experiment 1. Schematic of areas of interest in the
temporal decrement of tau protein phosphorylation.
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2.3

Experiment 2 Effect of Initial Alcohol Exposure on Temporal Decrement of Tau
Protein Phosphorylation in the Hippocampus
Experiment 2 assessed tau phosphorylation in the CA1, CA3, DG, and genu of the

hippocampus at four timepoints: 6DIV, 12DIV, 18DIV, 24DIV. At each timepoint
following 6DIV, there was an EtOH-exposed condition and a control condition. Control
slices received plain culture media at all timepoints. Experimental slices received five
days of 50mM EtOH exposure in culture media from 6DIV to 11DIV, and then received
plain culture media for the remainder of the experimental timeline; this was meant to
mimic a human third-trimester equivalent maternal alcohol binge of approximately
0.23BAC.
Plates housing control slices were placed into a Tupperware container with 50mL
of distilled water and placed into a Ziploc bag, filled with 5% CO2 and 95% air, and then
sealed and placed into the incubator. Ethanol-exposed slices which received 50mM
ethanol media between 6-11DIV were similarly placed in a Tupperware with 50mM
ethanol water, placed into a Ziploc bag filled with 5% CO2 and 95% air, and then sealed
and placed into the incubator. Atmospheric treatment was meant to prevent alcohol
evaporation during the five-day exposure. Regions of interest in Experiment 2 included
the CA1, CA3, DG, and genu of the hippocampus (Figure 2.3.1). Because the
modifications of interest for this experiment involve the effect of ethanol on tau protein
phosphorylation associated with immature microtubules within mossy fibers and Shaffer
collaterals between the CA3 and CA1, we included the additional measure of the
hippocampal genu to comprehensively address changes in tau protein phosphorylation in
and between these regions following alcohol exposure. Because this area is an ambiguous
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and contested region, traditional cytographic regional distinctions did not suffice for
exhaustive exploration of tau phosphorylation.

Figure 2.3.1 Regions of Interest for Experiment 2. Schematic of areas of interest in the
temporal decrement of tau protein phosphorylation following an initial 5-day alcohol
exposure.

2.4

Immunohistochemistry Procedure
For analysis of tau phosphorylation using immunohistochemistry (IHC), all slices

were first fixed in 10% formalin. Then the slices were washed twice in 1x PBS solution
and placed into an IHC buffer solution containing: 1x PBS, Triton detergent, and Bovine
Serum Albumin for 30 minutes. After, slices were again washed twice in 1x PBS
solution. The primary antibody used in these experiments was Phospho-Tau (Thr231)
Monoclonal Antibody (AT180) (Thermo Fisher, Waltham, MA). The antibody was
diluted 1:40 in IHC buffer solution and administered onto slices for 24 hours at 4°C; the
slices were then washed twice in 1x PBS. The secondary antibody used in these
experiments was Goat anti-Mouse IgG (H+L) Secondary Antibody, TRITC (Thermo
Fisher). The secondary antibody was diluted 1:200 in IHC buffer solution and
administered onto slices for 24 hours at 4°C; the slices were then washed twice in 1x PBS
prior to microscopic fluorescent imaging at 570 nm. Fluorescent intensity of all imaged
19

slices was measured using optical densitometry where greater fluorescent intensity
indicated greater concentration of threonine 231 phosphorylation on tau proteins.

2.5

Statistical Analysis
Statistical analyses were conducted to determine the effect of age and alcohol

exposure on the fluorescence of phosphorylated tau proteins in the hippocampus.
Multilevel model regression analyses were conducted in SAS using the DG as the
reference region for both Experiments 1 and 2 unless otherwise noted. The variables that
were included in the analyses were the effect of sex (male or female), EtOH exposure,
age, and an interaction between EtOH and age. Model assumptions were not violated.
Significance level was set at p ≤ 0.05, but marginal significance was reported if p ≤ 0.1.
Figures from Experiment 2 have been linearly transformed such that values are depicted
as %6DIV.
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CHAPTER 3. RESULTS
3.1

Experiment 1.
Results of multilevel models are presented in Table 3.1.1. The initial unconditional

means model (Model A) indicated an ICC of 0.38. Next, hippocampal region (CA1,
CA3) was added to the model, which significantly improved model fit, Δ deviance =
83.9, p < 0.001 (Model B). Adding male to the model did not significantly improve
model fit, Δ deviance = 1.4, n.s., and was therefore removed (Model C). However, adding
age to the model did significantly improve model fit, Δ deviance = 42.1, p < 0.001
(Model D). Evaluation of model coefficients indicated that age was a significant predictor
of the Level 1 intercept but not the effects of CA1 or CA3. Therefore, an additional
model was fit removing these interaction terms from the model (Model E). This model fit
the data equally well as Model D, Δ deviance = 3.0, n.s., and is therefore the preferred
model due to parsimony.
In Model E, intensity is estimated to be 24.83, p < 0.001, for the DG region at 6DIV.
Intensity is 4.43, p < 0.001, lower for each subsequent age group (12DIV, 18DIV, and
24DIV). These age group differences are the same for each region (Figure 3.1.1). However,
overall intensity is 7.81, p < 0.001, higher in the CA1 region compared to the DG region.
Intensity was equivalent for CA3 and DG regions.
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Table 3.1.1 Results from the multilevel model analysis for Experiment 1.
Effect
Intercept
Intercept
Male
Age
Residual Var
CA1
Intercept
Male
Age
CA3
Intercept
Male
Age
Level 1 Res Var
Deviance
Delta Deviance

Model A

Model B

Model C

Model D

Model E

20.89***

18.23***

18.73***
-1.20

24.28***

24.83***

18.88**

25.51***

24.96***

-4.07***
7.30**

-4.43***
7.17**

7.81***

8.22***
-1.00

9.49***

7.81***

-1.13
0.18

31.04***
814.2

11.16***
730.3
83.9***
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0.19
-0.03
11.09***
728.9
1.4

0.13

0.18

0.03
10.76***
686.8
42.1***

11.16***
689.8
3

Effect of DIV on Tau Phosphorylation in the Hippocampus
Mean p-Tau Thr231 Immunofluorescence

45

40
35
30
25
20
15
10
6DIV

12DIV
CA1

18DIV
CA3

24DIV

DG

Figure 3.1.1 Average effect of days in vitro on p-Tau Thr231 immunofluorescence
across 6, 12, 18, and 24DIV.
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3.2

Experiment 2
Results of multilevel models are presented in Table 3.2.1. The initial unconditional

means model (Model A) indicated an ICC of 0.55. Next, hippocampal region (CA1, CA3,
and Genu) was added to the model, which significantly improved model fit, Δ deviance =
219.00, p < 0.001 (Model B). Adding male to the model did not significantly improve
model fit, Δ deviance = 6.1, n.s., and was therefore removed (Model C). However, adding
age to the model did significantly improve model fit, Δ deviance = 22.6, p < 0.001
(Model D), as did adding EtOH, Δ deviance = 20.2, p < 0.001 (Model E), and the
interaction between Age and EtOH, Δ deviance = 15.9, p < 0.01 (Model F). Therefore,
Model F was the preferred model.
Model F (Table 3.2.1) indicated the mean intensity for control samples at 6DIV in
the DG region was 21.11, p < 0.001. Intensity is 1.76, p < 0.001, lower for each
subsequent age group (12DIV, 18DIV, and 24DIV) for control samples in the DG region.
Intensity is 5.44, p < 0.001, higher in the CA1 region compared to the DG region in
control samples at 6DIV. There is a significant difference in intensity between EtOH
samples in the Genu region compared to the DG region at 6DIV but not between control
samples, 2.44, p < 0.05.
Model F also indicated a significant EtOH by Age interaction due to the
significant improvement in model fit. However, none of these interaction terms were
significant when using DG as the reference region. Further probing of the interaction
identified significant terms only when CA1 was the reference region. Specifically, the
EtOH by Age interaction significantly predicted the difference between CA1 and CA3 on
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intensity, -2.21, p < 0.001 and marginally predicted the difference between CA1 and genu
on intensity, -1.20, p = 0.06 and the difference between CA1 and DG on intensity, -1.23,
p = 0.06.
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Table 3.2.1 Results from the multilevel model analysis for Experiment 2.
Effect
Intercept
Intercept
Male
Age
EtOH
EtOHxAge
Residual Var
CA1
Intercept
Male
Age
EtOH
EtOHxAge
CA3
Intercept
Male
Age
EtOH
EtOHxAge
Genu
Intercept
Male
Age
EtOH
EtOHxAge
Level 1 Res Var
Deviance
Delta Deviance

Model A

Model B

Model C

Model D

Model E

Model F

20.23***

18.35***

18.71***
-0.67

20.38***

20.24***

21.11***

-1.24***

-1.24***
0.26

24.20***

25.50***

25.50***

23.40***

23.25***

-1.76***
-1.71
1.20
22.84***

5.11***

4.91***
0.38

4.79***

4.55***

5.44***

0.20

0.20
0.45

-0.33
-1.56
1.23

1.29*

1.32

0.61

-0.43

-0.43
-0.05

-0.00
1.55
-0.98

2.24***

0.94

0.96

-0.26

-0.24
2.49***

14.73***
5833.5
22.6***

14.37***
5813.3
20.2***

-0.25
2.44*
0.03
14.14***
5797.4
15.9**

0.59

1.81***

20.03***
6075.1

14.81***
5856.1
219***

0.34
0.46

1.45**
0.66

14.81***
5850.0
6.1
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3.2.1

Differences in intensity across age groups based on region and EtOH exposure
Additional probing of the EtOH by Age interaction terms revealed that there was

a significant effect of age for control samples in each of the four regions: -1.76, p < 0.001
for DG (Figure 3.2.1.1); -1.76, p < 0.001 for CA3 (Figure 3.2.1.2); -2.09, p < 0.001 for
CA1 (Figure 3.2.1.3); -2.01, p < 0.001 for genu (Figure 3.2.1.4). However, there was only
a significant effect of age for EtOH samples in the CA3 region, -1.53, p < 0.01 (Figure
3.2.1.2). There was no significant effect of age for the other three regions: -.56 for DG
(Figure 3.2.1.1); .34 for CA1 (Figure 3.2.1.3); -.78 for genu (Figure 3.2.1.4). In the CA1
region, the effect of age was significantly stronger for control samples than EtOH
samples, 2.43, p < 0.001. In the genu region, the effect of age was marginally stronger for
control samples than EtOH samples, 1.24, p = 0.09. The figures for the regional means
for these data have been linearly transformed by the 6DIV average for their respective
condition, such that condition is represented as %6DIV.
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Figure 3.2.1.1 Effect alcohol and days in vitro on p-Tau Thr231 immunofluorescence
across 12, 18, and 24DIV in the dentate gyrus, shown as %6DIV. Tau phosphorylation
significantly declined between 6DIV and 24DIV for control samples, B = -1.76, p <
0.001. Tau phosphorylation did not significantly change between 6DIV and 24DIV for
samples exposed to alcohol, B = -0.56, n.s.
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Figure 3.2.1.2 Effect alcohol and days in vitro on p-Tau Thr231 immunofluorescence
across 12, 18, and 24DIV in the CA3, shown as %6DIV. Tau phosphorylation
significantly declined between 6DIV and 24DIV for both control samples, B = -1.76,
p < 0.001 and samples exposed to alcohol, B = -1.53, p < 0.01.
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Figure 3.2.1.3 Effect alcohol and days in vitro on p-Tau Thr231 immunofluorescence
across 12, 18, and 24DIV in the CA1, shown as %6DIV. Tau phosphorylation
significantly declined between 6DIV and 24DIV for control samples, B = -2.09, p <
0.001. Tau phosphorylation did not significantly change between 6DIV and 24DIV for
samples exposed to alcohol, B = 0.34, n.s.
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Figure 3.2.1.4 Effect of alcohol and days in vitro on p-Tau Thr231
immunofluorescence across 12, 18, and 24DIV in the hippocampal genu, shown as
%6DIV. Tau phosphorylation significantly declined between 6DIV and 24DIV for
control samples, B = -2.01, p < 0.001. Tau phosphorylation did not significantly
change between 6DIV and 24DIV for samples exposed to alcohol, B = -0.78, n.s.
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CHAPTER 4. DISCUSSION
4.1

Implications
Because the role of phosphorylated tau protein in the developing nervous system

has received little to no experimental or clinical attention, we intended to explore its
relationship with alcohol to draw implications related to FASDs. Above we have shown
that, under control conditions across 24 days in vitro (DIV), the fluorescence of
phosphorylated tau protein decrements in all regions of the rat hippocampus studied.
However, this effect is widely absent in tissue that encountered alcohol.
4.1.1

Experiment 1
In Experiment 1, we established the decremental nature of phosphorylated tau

fluorescence in the CA1, CA3, and DG over brief in vitro neonatal hippocampal
development. Because tau phosphorylation is elevated and associated with axonal
disorganization before and at birth, we anticipated that phosphorylated tau protein
fluorescence would be the brightest in the hippocampus when imaged closer to birth
(Brion, Smith, Couck, Gallo, & Anderto, 1993); the reduction of tau phosphorylation
from 6DIV to 24DIV, therefore, was unsurprising considering the control condition
permitted an unmodified environment for culturing healthy tissue.
The reduction in phosphorylated tau protein fluorescence could be a result of at
least two temporally regulated and functionally related processes that converge within the
insulin pathway: 1) diminished kinase activity of the GSK-3β protein, and/or 2) increased
phosphatase activity of protein phosphatase 2A (PP2A). As previously discussed, GSK-
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3β phosphorylates the tau protein at several amino acid residues, and GSK-3β is directly
implicated in the hyperphosphorylated state of the tau protein in damaged or diseased
hippocampi (Gong et al., 2005). Because GSK-3β is dynamically regulated during the
development and maturation of cells, GSK-3β activity may be associated with the
phosphorylation state of the tau protein across the duration of tissue culturing, such that,
as the tissue matured in vitro, GSK-3β hyperactivity became relatively stable under
control conditions which concurrently reduced tau protein phosphorylation (Jope &
Johnson, 2004).
Just as kinase activity is involved with phosphorylation of proteins, phosphatase
activity is involved with dephosphorylation of proteins. The most abundantly known
phosphatase in the CNS is the PP2A phosphatase which is responsible for
dephosphorylating 70%-90% of phosphorylated proteins, including the tau protein (Liu,
Grundke-Iqbal, Iqbal, & Gong, 2005; Eichhorn, Creyghton, & Bernards, 2009). In fact,
the phosphorylation state of serine/threonine residues on the tau protein is chiefly
regulated by GSK-3β phosphorylation and PP2A dephosphorylation, where PP2A
dephosphorylation is necessary for cellular morphogenesis and maturation (Avila, 2008;
Olsen et al., 2006). It is likely the inverse relationship between GSK-3β and PP2A that
resulted in the decrement of tau phosphorylation under control conditions in our tissue,
though metrics directly assessing the roles of PP2A and GSK-3β were not included in
these experiments.
4.1.2

Experiment 2
In Experiment 2, we established the decremental nature of phosphorylated tau

protein in the CA1, CA3, DG, and Genu over brief in vitro neonatal hippocampal culture
33

in the control condition; however, when tissue encountered alcohol, subsequent culturing
indicated that fluorescence of tau phosphorylation does not significantly change from
6DIV to 24DIV in the CA1, DG, or Genu. Our hypothesis regarding the temporally
sustained nature of tau phosphorylation in the alcohol-treated slices was supported by
these findings, except in the CA3 region. This is not unsurprising considering the
heterogeneity of glutamatergic NMDA receptor densities on pyramidal cell bodies within
the hippocampal subregions; autoradiographic experiments measuring [125I]MK-801
binding show that the CA1 region has the highest density of NMDARs compared to the
CA3 and DG regions (Butler et al., 2010). Because the hypothesized effect of alcohol
exposure and subsequent withdrawal is ultimately Ca2+-driven with relationship to GSK3β, higher densities of NMDARs would indicate a greater susceptibility to Ca2+-related
kinase activity (Dill, Wang, Zhou, & Li, 2008; Hartigan & Johnson, 1999; Xu et al.,
2004); this NMDAR/Ca2+ rationale, however, does not explain why tau phosphorylation
in the DG was sensitive to alcohol, but not the CA3, considering no significant
differences in NMDAR densities between the regions exist. Further investigation should
consider differential expression of GSK-3β by region. The heterogeneity of tau
phosphorylation between the CA3 and other hippocampal regions could illuminate
differences between mossy fiber and Shaffer collateral axonal development and how
constitutive tau phosphorylation and function is modified by alcohol exposure.
One possible explanation for the sustained p-tau florescence following alcohol
withdrawal is that the inverse relationship between PP2A and GSK-3β may have been
disrupted by alcohol exposure such that competition for phosphate homeostasis was
amplified and preferential for GSK-3β in the presence of cellular insult. The association
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between alcohol exposure, elevated Ca2+, and GSK-3β hyperactivity supports this
hypothesis (Chen et al., 2009; Hartigan & Johnson, 1999). As previously mentioned,
GSK-3β activity is primarily dictated by a cascade of events originating at the insulin
receptor, a receptor which becomes less sensitive to insulin following alcohol exposure,
promoting GSK-3β (Seiler, Henderson, & Rubin, 2000). This element of GSK-3β tau
hyperphosphorylation resulting from insulin insensitivity is well-established; however,
the role of PP2A and insulin signaling in relationship to tau hyperphosphorylation
remains under investigation (for a review, see Mandavia & Sowers, 2012).

4.2

Limitations
Notably, the fluorescence of tau phosphorylation is sustained following alcohol

exposure – whether that is the sustained phosphorylation of initially-expressed tau
proteins or detection of newly-expressed phosphorylated tau proteins remains unclear.
There is evidence that alcohol increases total tau protein concentrations (Hoffman et al.,
2019); therefore, it is possible that alcohol simply increased the expression of tau proteins
phosphorylated at threonine 231 (Thr231) rather than sustaining the initial tau
phosphorylation state. It may be erroneous to assume that tau phosphorylation is
saturated and immunofluorescent intensity is highest at birth, despite what we have
shown here. The functional difference between newly expressed Thr231 phosphorylated
tau proteins and sustained Thr231 phosphorylation on initially expressed tau proteins
would be difficult to discriminate in our model. Total tau immunofluorescence may be an
avenue to consider.
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The organotypic hippocampal slice culture (OHSC) model is integral for
investigating histological changes in developmental pathologies of neural tissues that are
otherwise inaccessible in humans. OHSC minimizes animal resources with an unmatched
degree of experimental control which is necessary for delineation of biochemical
pathways and subsequent potential therapeutic targets. However, the benefits of the
OHSC model are also its limitations: the tissue is divorced from the rest of the CNS and
peripheral nervous system (PNS) which are elements, in conjunction with learning and
behavior, that would undoubtedly influence CNS development with regard to alcohol
exposure.
We are interpreting the decrement of phosphorylated tau protein fluorescence as a
crude indication of axonal organization and maturation, though no complementary
confirmation was utilized in these experiments. Using myelin basic protein staining may
be an avenue by which such a confirmation could be made, where an inverse interaction
would better indicate axonal maturation and could provide insight into the relationship
between tau phosphorylation and neonatal myelination.
Finally, while our findings demonstrate that tau protein phosphorylation remains
elevated in all regions of the hippocampus except the CA3 following alcohol exposure,
these findings do not indicate that sustained tau phosphorylation confers any behavioral
or cognitive abnormalities observed in rodent models of or human patients with FASDs.
Taken together, behavioral and cognitive translational work must be conducted to
legitimize FASDs as a tauopathy in order to proceed with any meaningful therapeutic
pursuits.
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